Aveanna Healthcare Updates Stockholders Agreement and Board
I'm PortAI, I can summarize articles.
Aveanna Healthcare Holdings amended its Stockholders Agreement on November 13, 2025, restricting certain executives from transferring common stock without pre-approval, while allowing other stockholders to transfer shares freely. Christopher Gordon resigned as a Class II director, and Sam Weil from Bain Capital was appointed to the board. The most recent analyst rating on AVAH stock is a Hold with a $10.00 price target. AVAH's financial performance shows strong revenue and EBITDA growth but is constrained by high leverage and negative equity.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments